Auspex Pharmaceuticals

About:

Auspex Pharmaceuticals is a deuteration company developing therapeutics for depressive disorders.

Website: http://www.auspexpharma.com

Top Investors: Deerfield, Oxford Finance LLC, Panorama Capital, Thomas, McNerney & Partners, CMEA Capital

Description:

Auspex Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of novel medicines for the treatment of orphan diseases. The company's pipeline includes product candidates to address unmet medical needs in hyperkinetic movement disorders, such as chorea associated with Huntington’s disease, tardive dyskinesia, and Tourette syndrome, as well as other orphan indications.

Total Funding Amount:

$124M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

La Jolla, California, United States

Founded Date:

2001-01-01

Contact Email:

info(AT)auspexpharmaceuticals.com

Founders:

Number of Employees:

11-50

Last Funding Date:

2014-01-08

IPO Status:

Delisted

Industries:

© 2025 bioDAO.ai